ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth

被引:88
|
作者
Vives, Virginie
Su, Jian
Zhong, Shan
Ratnayaka, Indrika
Slee, Elizabeth
Goldin, Robert
Lu, Xin
机构
[1] UCL, Ludwig Inst Canc Res, London W1W 7BS, England
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, St Marys, Dept Pathol, London W2 1PG, England
关键词
D O I
10.1101/gad.374006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
ASPP2 stimulates the apoptotic function of the p53 family in vivo. We show here that ASPP2(-/-) pups died before weaning. This postnatal lethality was significantly enhanced in p53(+/-) background and both deletions are synthetic lethal. ASPP2(+/-) mice developed spontaneous tumors. The tumor onset was accelerated by gamma-irradiation or in p53(+/-) background. Tumors derived from ASPP2(+/-)mice retained wild-type ASPP2 allele even though some of them lost p53. These provide the first genetic evidence that ASPP2 is a haploinsufficient tumor suppressor that shares overlapping function(s) with p53 in mouse development and tumor suppression.
引用
收藏
页码:1262 / 1267
页数:6
相关论文
共 50 条
  • [1] 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice
    Ward, IM
    Difilippantonio, S
    Minn, K
    Mueller, MD
    Molina, JR
    Yu, XC
    Frisk, CS
    Ried, T
    Nussenzweig, A
    Chen, JJ
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (22) : 10079 - 10086
  • [2] ΔN-ASPP2 is a novel isoform of the ASPP2 tumor suppressor and a regulator of ASPP2 function
    Van Hook, Kathryn
    Wang, Zhiping
    Chen, Dexi
    Lee, Hun Joo
    Zhu, Zhiyi
    Lopez, Charles
    CANCER RESEARCH, 2011, 71
  • [3] Structural Basis for ASPP2 Recognition by the Tumor Suppressor p73
    Canning, Peter
    von Delft, Frank
    Bullock, Alex N.
    JOURNAL OF MOLECULAR BIOLOGY, 2012, 423 (04) : 515 - 527
  • [4] Inhibition of oncogenic ASPP2kappa(k), a dominant-negative Isoform of the Tumor Suppressor ASPP2, leads to Reactivation of p53 in Patients with Glioblastoma
    Hafner, M.
    Kampa, L.
    Ruiba, A.
    Ahrens, A. -L
    Sommer, I
    Kaelin, V
    Neidert, M.
    Buchauer, K.
    Henke, G.
    Arn, M.
    Plasswilm, L.
    Schittenhelm, M.
    Kampa-Schittenhelm, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 61 - 61
  • [5] New insights into the expanding complexity of the tumor suppressor ASPP2
    Kampa, Kerstin M.
    Bonin, Michael
    Lopez, Charles D.
    CELL CYCLE, 2009, 8 (18) : 2871 - 2876
  • [6] p53 tumor suppressor and cell growth
    Wallace, RW
    DRUG DISCOVERY TODAY, 1997, 2 (04) : 164 - 164
  • [7] Early epigenetic changes in mice haploinsufficient for tumor suppressor gene p53
    Peterson, Erica J.
    Taylor, Shirley M.
    CANCER RESEARCH, 2006, 66 (08)
  • [8] ASPP1 and ASPP2: Common activators of p53 family members
    Bergamaschi, D
    Samuels, Y
    Jin, BQ
    Duraisingham, S
    Crook, T
    Lu, X
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) : 1341 - 1350
  • [9] Tumor suppressor EAF2 cooperates with p53 in control of prostate tumorigenesis and vascularity
    Pascal, Laura E.
    Ai, Junkui
    Graham, Lara E.
    Xu, Jianhua
    Rigatti, Lora
    Pilch, Jan
    Zhou, Wang
    CANCER RESEARCH, 2011, 71
  • [10] ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival
    Van Hook, Kathryn
    Wang, Zhiping
    Chen, Dexi
    Nold, Casey
    Zhu, Zhiyi
    Anur, Pavana
    Lee, Hun-Joo
    Yu, Zhiyong
    Sheppard, Brett
    Dai, Mu-Shui
    Sears, Rosalie
    Spellman, Paul
    Lopez, Charles D.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 482 (04) : 1271 - 1277